+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pharmaceutical Market Access"

From
From
From
Psoriasis Pricing, Reimbursement, and Access - Product Thumbnail Image

Psoriasis Pricing, Reimbursement, and Access

  • Report
  • March 2019
  • 96 Pages
  • Global
Access Trends in Emerging Markets - Product Thumbnail Image

Access Trends in Emerging Markets

  • Report
  • February 2019
  • 156 Pages
  • Global
From
From
Market Access Trends in Europe - Product Thumbnail Image

Market Access Trends in Europe

  • Report
  • November 2018
  • 125 Pages
  • Europe
From
Big Pharma Diversification Strategies - Product Thumbnail Image

Big Pharma Diversification Strategies

  • Report
  • March 2018
  • 123 Pages
  • Global
From
Orphan Drug Access and Pricing in Emerging Markets - Product Thumbnail Image

Orphan Drug Access and Pricing in Emerging Markets

  • Report
  • January 2018
  • 59 Pages
  • Global
From
From
From
Regenerative Medicine in Pharma - Thematic Research - Product Thumbnail Image

Regenerative Medicine in Pharma - Thematic Research

  • Report
  • November 2020
  • 156 Pages
  • Global
From
Loading Indicator

The Pharmaceutical Market Access market is a sector of the pharmaceutical industry that focuses on the commercialization of drugs and other healthcare products. It involves the development of strategies to ensure that products are available to patients and healthcare providers in a timely and cost-effective manner. This includes activities such as pricing, reimbursement, distribution, and promotion. Market access teams work to ensure that products are available to the right patients, at the right time, and at the right price. Companies in the Pharmaceutical Market Access market include AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more